Related Experiment Video
Updated: May 30, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis]
Insights
Rheumatoid arthritis patients have a higher cardiovascular risk than healthy individuals, as shown by both ATP III and Reynolds Risk Score. The Reynolds Risk Score better identifies moderate to high cardiovascular risk in RA patients for timely intervention.
Area of Science:
- Cardiology
- Rheumatology
- Preventive Medicine
Background:
- Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular complications (CVC).
- Accurate risk assessment is crucial for timely intervention in RA patients.
- Existing risk scores may not fully capture the cardiovascular risk in this population.
Purpose of the Study:
- To compare the 10-year cardiovascular complication (CVC) risk assessed by the Adult Treatment Panel III (ATP III) and Reynolds Risk Score (RRS) in rheumatoid arthritis (RA) patients.
- To determine the contribution of C-reactive protein (CRP) to CVC development in RA patients.
- To evaluate the effectiveness of RRS in identifying RA patients needing closer cardiovascular monitoring.
Main Methods:
- The study included 116 RA patients and 85 healthy controls, matched for age and cardiovascular risk factors.
- 10-year CVC risk was calculated using ATP III and RRS.
- Serum levels of total cholesterol, HDL cholesterol, and highly sensitive C-reactive protein (hs-CRP) were measured.
Main Results:
- RA patients exhibited significantly higher 10-year CVC risk by both ATP III and RRS compared to controls (p < 0.05).
- The Reynolds Risk Score identified a higher proportion of RA patients with moderate to high cardiovascular risk compared to ATP III, particularly in males.
- A positive correlation was observed between RRS and carotid intima-media thickness in RA patients (r = 0.44; p < 0.001).
Conclusions:
- The Reynolds Risk Score is a valuable tool for identifying RA patients at moderate to high cardiovascular risk.
- Implementing RRS can facilitate timely and targeted cardiovascular medication in RA patients.
- Further research may explore the role of hs-CRP in refining cardiovascular risk prediction in RA.
Aim:
To compare 10-year risk of cardiovascular complications (CVC) assessed by Adult Treatment Panel III (ATP III) and Reynolds Risk Score (RRS); to specify contribution of C-reactive protein (CRP) to development of CVC in patients with rheumatoid arthritis (RA).
Material And Methods:
The trial included 116 RA patients (100 females and 16 males) and 85 healthy subjects (63 females and 22 males) under 55 years of age free of clinical symptoms of cardiovascular diseases. RA duration and activity were the same in men and women. The patients and controls were matched by age, incidence of standard risk factors (RF). The 10-year risk of CVC development was estimated by two scales--ATP III and RRS. Total cholesterin, HDLP cholesterin were measured with standard enzyme tests, concentration of CRP was assessed by highly sensitive immune nephelometry.
Results:
The 10-year risk of CVC was higher in RA patients both by ATP III (1.8 - 1;10%) and RRS (2.6 - 2; 7)% compared to the controls (1 - 1;3)% and (1.2 - 1;4)% (p < 0.05). In male RA patients RRS is higher than in females - 7 (3.5; 12)% and 2 (1;2)%, respectively (p < 0.001). Re-calculation from the scale ATP III to RRS has changed the risk in 17 (17%) females and 7 (44%) males with RA. As a result, the number of RA patients with a low CVC risk decreased, with a moderate risk rose 2 times, with a high risk was the same. RRS dependence on the disease duration, RA activity (DAS28) was not registered. RA patients showed a positive correlation of RRS with thickness of the intima-media complex of the carotid arteries (r = 0.44; p < 0.001).
Conclusion:
Introduction of a new prognostic scale RRS allows isolation of groups of patients with moderate and high CVC risk and timely medication of such patients.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
